ALD306
ALD306 is a human monoclonal antibody (mAb) targeting PCSK9. ALD306 can be used in Hypercholesterolaemia research[1].
Product Specifications
Product Name Alternative
ALD309
UNSPSC
12352203
Target
PCSK9
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Smiles
[ALD306]
References & Citations
[1]Pederson S, et al. Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine. Front Immunol. 2021 Oct 25;12:765822.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1117572-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Cytochrome b-c1 complex subunit 6 (qcr6)
Ask
View Details MBS1117572-02 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Cytochrome b-c1 complex subunit 6 (qcr6)
Ask
View Details MBS1117572-03 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe Cytochrome b-c1 complex subunit 6 (qcr6)
Ask
View Details MBS1117572-04 0.1 mg (Yeast)
Recombinant Schizosaccharomyces pombe Cytochrome b-c1 complex subunit 6 (qcr6)
Ask
View Details